Trial Profile
Open-label study of aripiprazole in individuals at risk for chronic mental illness
Status:
Discontinued
Phase of Trial:
Phase II/III
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 30 Dec 2005 New trial record.